Extract
Sarcoidosis is a systemic disease of an unknown aetiology, in which noncaseating granulomas are formed in one or multiple organs, with pulmonary involvement in >90% of the sarcoidosis patients [1]. Pulmonary hypertension (PH), defined as a mean pulmonary artery pressure of ≥25 mmHg by right heart catheterisation (RHC) [2], is a well recognised complication of sarcoidosis, associated with significant increase in mortality [3, 4]. Although the first case of PH in sarcoidosis was described in 1949 [5], the exact prevalence remains unclear.
Abstract
The prevalence of pulmonary hypertension in sarcoidosis seems to differ between ethnicities and was never investigated in a Caucasian cohort. This study shows a prevalence of 3% in a Caucasian cohort, significantly lower compared to other ethnicities. http://bit.ly/2kRMrap
Footnotes
Conflict of interest: M.P. Huitema has nothing to disclose.
Conflict of interest: A.L.M. Bakker has nothing to disclose.
Conflict of interest: J.J. Mager has nothing to disclose.
Conflict of interest: B.J.W.M. Rensing has nothing to disclose.
Conflict of interest: F. Smits has nothing to disclose.
Conflict of interest: R.J. Snijder has nothing to disclose.
Conflict of interest: J.C. Grutters has nothing to disclose.
Conflict of interest: M.C. Post has nothing to disclose.
Support statement: Funding was received from ZonMw (The Netherlands Organisation for Health Research and Development). Funding information for this article has been deposited with the Crossref Funder Registry.
- Received November 29, 2018.
- Accepted June 12, 2019.
- Copyright ©ERS 2019
INDIVIDUALS
Log in using your username and password
LIBRARY USERS
Log in through your institution
Purchase access
CONTACT US
If you have any questions about the ERS publications website, please contact journals@ersnet.org
